The effectiveness and availability of conservative therapies for osteonecrosis of the femoral head (ONFH) are limited. Transplantation of bone marrow mesenchymal stem cells (BMSCs) combined with Bio-Oss, which is a good bone scaffold biomaterial for cell proliferation and differentiation, is a new potential therapy. Of note, the expression of miRNAs was significantly modified in cells cultured with Bio-Oss, and MiR-214 was correlated positively with osteonecrosis. Furthermore, miR-214 was upregulated in cells exposed to Bio-Oss.
OBJECTIVE:
To investigate whether targeting miR-214 further improves the transplantation effect.
METHODS:
We treated BMSCs with agomiR-214 (a miR-214 agonist), antagomiR-214 (a miR-214 inhibitor), or vehicle, followed by their transplantation into ONFH model rats.
RESULTS:
Histological and histomorphometric data showed that bone formation was significantly increased in the experimental groups (Bio-Oss and BMSCs treated with antagomiR-214) compared with other groups.
CONCLUSIONS:
miR-214 participates in the inhibition of osteoblastic bone formation, and the inhibition of miR-214 to bone formation during transplantation therapy with Bio-Oss combined with BMSCs for ONFH.
ChughtaiM.PiuzziN.S.KhlopasA.JonesL.C.GoodmanS.B. and MontM.A., An evidence-based guide to the treatment of osteonecrosis of the femoral head, Bone Joint J99-B(10) (2017), 1267–1279.
2.
VillaJ.C.HusainS.van der ListJ.P.GianakosA. and LaneJ.M., Treatment of pre-collapse stages of osteonecrosis of the femoral head: A systematic review of randomized control trials, HSS J12 (2016), 261–271.
3.
DuJ.LiuW.JinT.ZhaoZ.BaiR.XueH., A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head, Oncotarget7(42) (2016), 68434–68441.
4.
ZhangY.L.ChenS.AiZ.S.GaoY.S.MeiJ. and ZhangC.Q., Osteonecrosis of the femoral head, nonunion and potential risk factors in Pauwels grade-3 femoral neck fractures: A retrospective cohort study, Medicine95 (2016), e3706.
5.
YangF.ZhuZ.Z.WengS.Y.GaoY.S.WangY.ShengJ.G., Morphological changes of the trabecular bone in osteonecrosis of the femoral head, Int J Clin Exp Pathol9 (2016), 4203–4211.
6.
KuboT.UeshimaK.SaitoM.IshidaM.AraiY. and FujiwaraH., Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan, J Orthop Sci21 (2016), 407–413.
7.
SaitoM.UeshimaK.IshidaM.HayashiS.IkegamiA.OdaR., Alcohol-associated osteonecrosis of the femoral head with subsequent development in the contralateral hip: A report of two cases, J Orthop Sci21 (2016), 870–874.
8.
HanN.LiZ.C.CaiZ.D.YanZ.Q.HuaY.Q. and XuC., P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head, J Cell Mol Med20 (2016), 2173–2182.
9.
HsuS.-L.WangC.-J.LeeM.S.-S.ChanY.-S.HuangC.-C. and YangK.D., Cocktail therapy for femoral head necrosis of the hip, Arch Orthop Trauma Surg130(1) (2010), 23.
10.
YamaguchiR.YamamotoT.MotomuraG.IkemuraS.IwasakiK.ZhaoG., Effects of an anti-platelet drug on the prevention of steroid-induced osteonecrosis in rabbits, Rheumatology51(5) (2011), 789–793.
11.
AmanatullahD.F.StraussE.J. and Di CesareP.E., Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management, Am. J. Orthop.40 (2011), E186–E192.
12.
PeledE.DavisM.AxelmanE.NormanD. and NadirY., Heapranase role in the treatment of avascular necrosis of femur head, Thromb Res131(1) (2013), 94–98.
13.
PangC.G.JiangW.X.JiangC.Q. and XuD.M., Effects of allogenic bone marrow mesenchymal stem cells combining with bionics electromagnetic fields on osteonecrosis of femoral head in rabbits, Chin J Joint Surg6(5) (2012), 756–763.
14.
PersianiP.De CristoC.GraciJ.NoiaG.GurziM. and VillaniC., Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells, Acta Orthop Belg81(3) (2015), 406–412.
15.
ZhaoD.LiuB.WangB.YangL.XieH.HuangS., Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head, BioMed Res Int (2015), 2015.
16.
ZhaoD.ZhangF.WangB.LiuB.LiL.KimS.Y., Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version), J Orthop Translat21 (2020), 100–110.
17.
MankinH.J., Nontraumatic necrosis of bone (osteonecrosis), N Engl J Med.326 (1992), 1473–1479.
18.
JonesK.B.SeshadriT.KrantzR.KeatingA. and FergusonP.C., Cell-based therapies for osteonecrosis of the femoral head, Biol Blood Marrow Transplant14 (2008), 1081–1087.
19.
ZhaoD.CuiD.WangB.TianF.GuoL.YangL., Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells, Bone50(1) (2012), 325–330.
20.
RezaeiM.JamshidiS.SaffarpourA.AshouriM.RahbarghaziR.RoknA.R., Transplantation of bone marrow-derived mesenchymal stem cells, platelet-rich plasma, and fibrin glue for periodontal regeneration, Int J Periodontics Restorative Dent39(1) (2019), e32–e45.
21.
LimY.W.KimY.S.LeeJ.W. and KwonS.Y., Stem cell implantation for osteonecrosis of the femoral head, Exp Mol Med45 (2013), e61.
22.
ChenX.WangZ.DuanN.ZhuG.SchwarzE.M. and XieC., Osteoblast-osteoclast interactions, Connect Tissue Res59(2) (2018), 99–107.
23.
WangF.LiQ. and WangZ., A comparative study of the effect of Bio-Oss® in combination with concentrated growth factors or bone marrow-derived mesenchymal stem cells in canine sinus grafting, J Oral Pathol Med46(7) (2017), 528–536.
24.
KimS.S. and KimB.S., Comparison of osteogenic potential between apatite-coated poly(lactide-co-glycolide)/hydroxyapatite particulates and Bio-Oss, Dent Mater J27(3) (2008), 368–375.
25.
ZhangP.DingL. and KasugaiS., Effect of doxycycline doped bone substitute on vertical bone augmentation on rat calvaria, Dent Mater J38(2) (2019), 211–217.
26.
AnnalisaP.FurioP.IlariaZ.AnnaA.LucaS.MarcellaM., Anorganic bovine bone and a silicate-based synthetic bone activate different microRNAs, J Oral Sci50(3) (2008), 301–307.
27.
PalmieriA.PezzettiF.BrunelliG.MartinelliM.Lo MuzioL.ScaranoA., Anorganic bovine bone (Bio-Oss) regulates miRNA of osteoblast-like cells, Int J Periodontics Restorative Dent30(1) (2010), 83–87.
28.
AdairJ.E. and WeitzmanM.D., Applying the speed-dating model and other approaches to foster future leaders for the American Society of Gene and Cell Therapy, Mol Ther22(8) (2014), 1397–1398.
29.
HeL. and HannonG.J., MicroRNAs: small RNAs with a big role in gene regulation, Nature Rev Genet5 (2004), 522–531.
30.
BartelD.P., MicroRNAs: Target recognition and regulatory functions, Cell136 (2009), 215–233.
31.
LianJ.B.SteinG.S.van WijnenA.J.SteinJ.L.HassanM.Q.GaurT., MicroRNA control of bone formation and homeostasis, Nat Rev Endocrinol8 (2012), 212–227.
32.
PapaioannouG.MirzamohammadiF. and KobayashiT., MicroRNAs involved in bone formation, Cell Mol Life Sci71(24) (2014), 4747–4761.
33.
SuttamanatwongS., MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis, Connect Tissue Res58(1) (2017), 90–102.
34.
ImamuraK.TachiK.TakayamaT.ShoharaR.KasaiH.DaiJ., Released fibroblast growth factor18 from a collagen membrane induces osteoblastic activity involved with downregulation of miR-133a and miR-135a, J Biomater Appl32(10) (2018), 1382–1391.
35.
HaoC.YangS.XuW.J.K.ShenYeS.LiuX., MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3, Sci Rep6 (2016), 22599.
36.
ZhangZ.JinA. and YanD., MicroRNA 206 contributes to the progression of steroid induced avascular necrosis of the femoral head by inducing osteoblast apoptosis by suppressing programmed cell death 4, Mol Med Rep17(1) (2018), 801–808.
37.
LiZ.YangB.WengX.TseG.ChanM.T.V. and WuW.K.K., Emerging roles of microRNAs in osteonecrosis of the femoral head, Cell Prolif51(1) (2018).
38.
WangX.GuoB.LiQ.PengJ.YangZ.WangA., miR-214 targets ATF4 to inhibit bone formation, Nat Med19(1) (2013), 93–100.
KomoriT.YagiH.NomuraS.YamaguchiA.SasakiK.DeguchiK., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell89(5) (1997), 755–764.
41.
CuriM.M.DibL.L. and PintoD.S., Management of solid ameloblastoma of the jaws with liquid nitrogen spray cryosurgery, Oral Surg Oral Med Oral Pathol Oral Radiol Endod84(4) (1997), 339–344.
42.
CostaF.W.BritoG.A.PessoaR.M. and Studart-SoaresE.C., Histomorphometric assessment of bone necrosis produced by two cryosurgery protocols using liquid nitrogen: An experimental study on rat femurs, J Appl Oral Sci19(6) (2011), 604–609.
43.
SugayaH.MishimaH.GaoR.KaulS.C.WadhwaR.AotoK., Fate of bone marrow mesenchymal stromal cells following autologous transplantation in a rabbit model of osteonecrosis, Cytotherapy18(2) (2016), 198–204.
44.
JuanA.H.KumarR.M.MarxJ.G.YoungR.A. and SartorelliV., Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonicstem cells, Mol Cell36(1) (2009), 61–74.
45.
WangY.LiuW.MasuyamaR.FukuyamaR.ItoM.ZhangQ., Pyruvate dehydrogenase kinase 4 induces bone loss at unloading by promoting osteoclastogenesis, Bone50(1) (2012), 409–419.
46.
ZhengD.YangX.ShengD.YuD.LiangG.GuoL., Pou4f2-GFP knock-in mouse line: A model for studying retinal ganglion cell development, Genesis54(10) (2016), 534–541.
47.
McDonaldM.M.MorseA.SchindelerA.MikulecK.PeacockL.ChengT., Homozygous Dkk1 knockout mice exhibit high bone mass phenotype due to increased bone formation, Calcif Tissue Int102(1) (2018), 105–116.
48.
WangC.SunW.LingS.WangY.WangX.MengH., AAV-Anti-miR-214 prevents collapse of the femoral head in osteonecrosis by regulating osteoblast and osteoclast activities, Mol Ther Nucleic Acids18 (2019), 841–850.
49.
LiQ.S.MengF.Y.ZhaoY.H.JinC.L.TianJ. and YiX.J., Inhibition of microRNA-214-5p promotes cell survival and extracellular matrix formation by targeting collagen type IV alpha 1 in osteoblastic MC3T3-E1 cells, Bone Joint Res6(8) (2017), 464–471.
50.
MohamadN.NabihE.S.ZakariaZ.M.NagatyM.M. and MetwalyR.G., Insight into the possible role of miR-214 in primary osteoporosis via osterix, J Cell Biochem120(9) (2019), 15518–15526.
51.
OuL.SunT.ChengY.HuangL.ZhanX.ZhangP., MicroRNA-214 contributes to regulation of necroptosis via targeting ATF4 in diabetes-associated periodontitis, J Cell Biochem120(9) (2019), 14791–14803.
52.
RickertD.VissinkA.SlotW.J.SauerbierS.MeijerH.J. and RaghoebarG.M., Maxillary sinus floor elevation surgery with Bio-Oss mixed with a bone marrow concentrate or autogenous bone: Test of principle on implant survival and clinical performance, Int J Oral Maxillofacial Surg43 (2014), 243–247.
53.
LiK.-C.ChangY.-H.HsuM.-N.LoS.-C.LiW.-H. and HuY.-C., Baculovirus-mediated miR-214 knockdown shifts osteoporotic ASCs differentiation and improves osteoporotic bone defects repair, Sci Rep7(1) (2017), 16225.
54.
YaoS.ZhaoW.OuQ.LiangL.LinX. and WangY., MicroRNA-214 suppresses osteogenic differentiation of human periodontal ligament stem cells by targeting ATF4, Stem Cells Int2017 (2017), 3028647.
55.
LuX.-Z.YangZ.-H.ZhangH.-J.ZhuL.-L.MaoX.-L. and YuanY., MiR-214 protects MC3T3-E1 osteoblasts against H2O2-induced apoptosis by suppressing oxidative stress and targeting ATF4, Eur Rev Med Pharmacol Sci21(21) (2017), 4762–4770.
56.
LiN.BaiY.ZhouG.MaY.TanM.QiaoF., miR-214 attenuates aortic valve calcification by regulating osteogenic differentiation of valvular interstitial cells, Mol Ther Nucleic Acids22 (2020), 971–980.
